mRNA technologies are revolutionizing medicine. Which diseases are they aimed at? How quickly are the new therapies coming along? And how do the innovative active ingredients enter the body? A numerical overview
Beyond COVID-19
Areas of application of mRNA therapeutics and vaccines1 in clinical development, in percent Source: Roots Analysis, as of January 2023
¹ Therapeutics for which the status information is available
Oncological disorders
Genetic disorders
Pulmonary disorders
Autoimmune disorders
Other disorders
mRNA takes off
Start of clinical trials with RNA therapeutics
Source: Beacon Intelligence, as of July 2022
Nanoparticles in the lead
The most important transport systems for mRNA active ingredients by number of product developments
Source: Beacon Intelligence, as of January 2023
Under the skin
Routes of administration of mRNA therapeutics and vaccines, in percent Source: Roots Analysis, as of January 2023
2 Including intradermal, subcutaneous, and external
Sector pioneers
The most important developers of mRNA therapeutics by number of product developments
Source: Beacon Intelligence, as of July 2022
